Catheter-based sympathetic renal denervation (RDN) is a novel iteration of a historical but effective treatment for hypertension. A number of different device systems have demonstrated a ...
The Symplicity studies suggest that intravascular renal sympathetic nervous denervation improves blood pressure in patients with resistant hypertension, thus potentially opening a market for ...
A minimally invasive procedure used to treat resistant hypertension or high blood pressure that does not respond to other ...
Medtronic says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with ...
On Monday, the Centers for Medicare & Medicaid Services (CMS) initiated a national coverage analysis of renal denervation for ...
The Paradise uRDN system is currently commercially available for patients in the US having received FDA approval in November 2023. It is indicated to reduce blood pressure as an adjunctive treatment ...
Cannon, W. B., and Rosenblueth, A., “The Supersensitivity of Denervated Structures. A Law of Denervation” (Macmillan Co., New York, 1949). Whitby, L. G., Axelrod ...
U.S. Medicare coverage of renal denervation (RDN) for uncontrolled hypertension may soon be a fact of life if the manufacturers of these systems have their way. CMS opened a national coverage analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback